Skip to main content

Featured

Market Jitters Return as Cooler CPI Surprises Wall Street

A softer‑than‑expected U.S. Consumer Price Index reading sent a ripple through financial markets today, creating an unusual dynamic: good news on inflation, but renewed pressure on major stock indexes. A Cooling CPI, but a Nervous Market The latest CPI report showed inflation easing more than economists anticipated. Under normal circumstances, that would be a welcome sign—suggesting the Federal Reserve may have more room to consider rate cuts later in the year. But markets don’t always behave logically in the moment. Today, the S&P 500, Dow Jones Industrial Average, and Nasdaq all slipped as investors reassessed what the data means for corporate earnings, interest‑rate expectations, and the broader economic outlook. Why Stocks Reacted This Way Several factors contributed to the pullback: Profit‑taking after recent market highs Concerns that cooling inflation reflects slowing demand Uncertainty about the Fed’s next move , even with softer price pressures Sector rotation ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment